Feedback / Questions
isomyosamine (MYMD-1) - MyMD Pharma, Akers Biosci
https://www.businesswire.com/news/home/20220411005985/en/MyMD-Pharmaceuticals%E2%80%99-Lead-Compound-MYMD-1-Demonstrates-Superior-Anti-inflammatory-Effects-over-Top-Selling-Therapies-in-a-Pivotal-Preclinical-Model-of-Rheumatoid-Arthritis
Apr 12, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next